Skip to main content
SpringerLink
Log in

Exogenous Exposure: Occupation and Environment

  • Chapter
Screening and Preventive Diagnosis with Radiological Imaging

Part of the book series: Medical Radiology ((Med Radiol Diagn Imaging))

  • 769 Accesses

Abstract

Asbestos is a general term for a heterogeneous group of hydrated magnesium silicate minerals that have in common a tendency to separate into fibers (Committee on Nonoccupational Health Risks 1984). Asbestos fibers have great tensile strength, heat resistance, and acid resistance, varieties are also flexible (American Thoracic Society 2004).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 249.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Aberle D, Balmes JR (1991) Computed tomography of asbestos-related pulmonary parenchymal and pleural diseases. Clin Chest 12:115–131

    CAS  Google Scholar 

  • American Thoracic Society (2004) Diagnosis and initial management of non-malignant diseases related to asbestos. Am J Respir Crit Care Med 170:691–715

    Google Scholar 

  • Berry G (1981) Mortality of workers certified by pneumoconiosis medical panels as having asbestosis. Br J Ind Med 38:130–137

    CAS  PubMed  Google Scholar 

  • Boutin C et al. (1994) Intrapleural treatment with recombinant gamma-interferon in early stage malignant pleural mesothelioma. Cancer 74:2460–2467

    CAS  PubMed  Google Scholar 

  • Brownson T (1998) Current and historical American asbestos regulations. Monaldi Arch Chest Dis 53:181–185

    CAS  PubMed  Google Scholar 

  • Cleemput J van et al. (2001) Surface of localized pleural plaques quantitated by computed tomography screening. No relation with cumulative asbestos exposure and no effect on lung function. Am J Respir Crit Care Med 163:705–710

    PubMed  Google Scholar 

  • Committee on Nonoccupational Health Risks (1984) Asbestiform fibers: nonoccupational health risks. Committee on Nonoccupational Health Risks of Asbestiform Fibers, Board of Toxicology and Environmental Health Hazards, National Research Council. National Academics Press, Washington DC, pp 24–29

    Google Scholar 

  • Connelly RR et al. (1987) Demographic patterns for mesothelioma in the United States. J Natl Cancer Inst 78:1053–1060

    CAS  PubMed  Google Scholar 

  • Copley SJ et al. (2001) Functional consequences of pleural disease evaluated with chest radiography and CT. Radiology 220:237–243

    CAS  PubMed  Google Scholar 

  • Copley SJ et al. (2007) Asbestos-induced and smoking-related disease: apportioning pulmonary function deficit by using thin-section CT. Radiology 242:258–266

    PubMed  Google Scholar 

  • Cugell DW, Kamp DW (2004) Asbestos and the pleura: a review. Chest 125:1103–1117

    PubMed  Google Scholar 

  • Das M et al. (2007) Asbestos surveillance program Aachen (ASPA): initial results from baseline screening for lung cancer in asbestos-exposed high risk individuals using low-dose multidetector-row CT. Eur Radiol 17:1193–1199

    PubMed  Google Scholar 

  • De Pangher MV et al. (1993) Prognostic factors of malignant pleural mesothelioma of the pleura. Cancer 72:410–417

    Google Scholar 

  • Eibel R et al. (2003) The role of new imaging techniques in diagnosis and staging of malignant pleural mesothelioma. Curr Opion Oncol 15:131–138

    Google Scholar 

  • Epler GR et al. (1982) Prevalence and incidence of benign asbestos pleural effusion in a working population. JAMA 247:617–622

    CAS  PubMed  Google Scholar 

  • Flehinger BJ, Kimmel M, Melamed MR (1992) Survival from early lung cancer: implications for screening. Chest 101:1013–1018

    CAS  PubMed  Google Scholar 

  • Fontana RS et al. (1986) Lung cancer screening: the Mayo program. J Occup Med 28:746–750

    CAS  PubMed  Google Scholar 

  • Goldberg M, Luce D (2005) Can exposure to very low levels of asbestos induce pleural mesothelioma? Am J Respir Crit Care Med 172:939–943

    PubMed  Google Scholar 

  • Health Effects Institute (1991) Asbestos in public and commercial buildings: a literature review and synsthesis of current knowledge. Health Effects Institute — Asbestos Research, pp 8–10

    Google Scholar 

  • Henschke CI et al. (1999) Early lung cancer action project: overall design and findings from baseline screening. Lancet 354:99–105

    CAS  PubMed  Google Scholar 

  • Hering KG et al. (2004) Standardisierte CT/HRCT-Klassifikation der Bundesrepublik Deutschland für arbeits-und umweltbedingte Thoraxerkrankungen. Radiologe 44:500–511

    CAS  PubMed  Google Scholar 

  • Herndon JE et al. (1998) Factors predictive of survival among 337 patients with mesothelioma treated between 1984 and 1994 by the Cancer and Leukemia Group B. Chest 113:723–731

    CAS  PubMed  Google Scholar 

  • Hillerdal G (1983) Malignant mesothelioma 1982: review of 4710 published cases. Br J Dis Chest 77:321–343

    CAS  PubMed  Google Scholar 

  • Hillerdal G et al. (1987) Benign asbestos pleural effusion: 73 exudates in 60 patients. Eur J Respir Dis 71:113–121

    CAS  PubMed  Google Scholar 

  • Jones RN et al. (1988) The radiographic pleural abnormalities in asbestos exposure: relationship to physiologic abnormalities. J Thorac Imaging 3:57–66

    CAS  PubMed  Google Scholar 

  • Kamp DW, Weitzman SA (1999) The molecular basis of asbestos induced lung injury. Thorax 54:638–652

    CAS  PubMed  Google Scholar 

  • Kaneko M et al. (1996) Peripheral lung cancer: screening and detection with low-dose spiral CT versus radiography. Radiology 201:798–802

    CAS  PubMed  Google Scholar 

  • Knisely BL et al. (2000) MR imaging of the pleura and chest wall. Magn Reson Imaging Clin N Am 8:125–141

    CAS  PubMed  Google Scholar 

  • Light RW (1995) Pleural diseases, 3rd edn. Williams & Wilkins, Baltimore, MD, USA

    Google Scholar 

  • Marom EM et al. (2002) The role of imaging in malignant pleural mesothelioma. Sem Oncol 29:26–35

    Google Scholar 

  • McDonald JC, McDonald AD (1997) The epidemiology of mesothelioma in historical context. Eur Respir J 9:1932–1942

    Google Scholar 

  • McGavin CR, Sheers G (1984) Diffuse pleural thickening in asbestos workers: disability and lung function abnormalities. Thorax 39:604–607

    CAS  PubMed  Google Scholar 

  • McLoud TC (1988) The use of CT in the examination of asbestos-exposed persons. Radiology 169:862–863

    CAS  PubMed  Google Scholar 

  • Melamed MR et al. (1984) Screening for lung cancer: results of the Memorial Sloan-Kettering study in New York. Chest 86:44–53

    CAS  PubMed  Google Scholar 

  • Miettinen OS (2000) Screening for lung cancer: can it be cost-effective? CMAJ 162:1431–1436

    CAS  PubMed  Google Scholar 

  • Mossman BT et al. (1990) Asbestosis: scientific developments and implications for public policy. Science 247:294–301

    CAS  PubMed  Google Scholar 

  • Mossman BT et al. (2002) SV40, growth factors, and mesothelioma: another piece of the puzzle. Am J Respir Cell Mol Biol 26:167–170

    CAS  PubMed  Google Scholar 

  • Müller N (1993) Imaging of the pleura [review]. Radiology 186:297–309

    PubMed  Google Scholar 

  • Nesbitt JC et al. (1995) Survival of early-stage lung cancer. Ann Thorac Surg 60:466–472

    CAS  PubMed  Google Scholar 

  • Nowak D et al. (2005). Screening of lung cancer — state of the art. Pneumologie 59:178–191

    CAS  PubMed  Google Scholar 

  • Ong ST, Vogelzang NJ (1996) Chemotherapy in malignant pleural mesothelioma. A review. J Clin Oncol 14:1007–1017

    CAS  PubMed  Google Scholar 

  • Pass HI et al. (2005) Asbestos exposure, pleural mesothelioma, and serum osteopontin levels. N Engl J Med 13:1564–1573

    Google Scholar 

  • Peto J et al. (1999) The European mesothelioma epidemic. Br J Cancer 79:666–672

    CAS  PubMed  Google Scholar 

  • Remy-Jardin M et al. (2004) Asbestos-related pleuropulmonary diseases: evaluation with low-dose four-detector row spiral CT. Radiology 233:182–190

    PubMed  Google Scholar 

  • Ren H et al. (1991) Pleural plaques do not predict asbestosis: high-resolution computed tomography and pathology study. Mod Pathol 4:201–209

    CAS  PubMed  Google Scholar 

  • Roggli VL, Sanders LL (2000) Asbestos content of lung tissue and carcinoma of the lung: a clinicopathologic correlation and mineral fiber analysis of 234 cases. Ann Occup Hyg 44:109–117

    CAS  PubMed  Google Scholar 

  • Ross RM (2003) The clinical diagnosis of asbestosis in this century requires more than a chest radiograph. Chest 124:1120–1128

    PubMed  Google Scholar 

  • Sargent EN et al. (1984) Subpleural fat pads in patients exposed to asbestos: distinction from non-calcified pleural plaques. Radiology 152:273–277

    CAS  PubMed  Google Scholar 

  • Scherperel A et al. (2006) Soluble mesothelin-related peptides in the diagnosis of malignant mesothelioma. Am J Respir Crit Care Med 173:1155–1160

    Google Scholar 

  • Schwartz DA et al. (1990) Determinants of restrictive lung function in asbestos-induced pleural fibrosis. J Appl Physiol 68:1932–1937

    CAS  PubMed  Google Scholar 

  • Senyigit A et al. (2000) Malignant pleural mesothelioma caused by environmental exposure to asbestos in the southeast of turkey: CT findings in 117 patients. Clin Invest Resp 67:615–622

    CAS  Google Scholar 

  • Sider L et al. (1987) Changes on radiographs of wives of workers exposed to asbestos. Radiology 164:723–726

    CAS  PubMed  Google Scholar 

  • Sone S et al. (1998) Mass screening for lung cancer with mobile spiral computed tomography scanner. Lancet 351:1242–1245

    CAS  PubMed  Google Scholar 

  • Sugarbaker DJ et al. (1999) Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients. J Thorac Cardiovasc Surg 117:54–63

    CAS  PubMed  Google Scholar 

  • Sterman DH et al. (1998) Adenovirus-mediated herpes simplex virus with thymidine kinase/ganciclovir gene therapy in patients with localized malignancy: results of a phase I clinical trial in malignant mesothelioma. Hum Gene Ther 9:1083–1092

    CAS  PubMed  Google Scholar 

  • Strauss GM (1998) Lung cancer screening and randomized population trials. International Conference on Prevention and Early Diagnosis of Lung Cancer, Varese, Italy, December 9–10

    Google Scholar 

  • Takita H, Dougherthy TJ (1995) Intracavitary photodynamic therapy for malignant pleural mesothelioma. Semin Surg Oncol 11:368–371

    CAS  PubMed  Google Scholar 

  • Tiitola M et al. (2002) Computed tomography screening for lung cancer in asbestos-exposed workers. Lung Cancer 35:17–22

    PubMed  Google Scholar 

  • Tossavainen A (2000) International expert meeting on new advances in the radiology and screening of asbestos-related disease. Scand J Work Environ Health 26:449–454

    CAS  PubMed  Google Scholar 

  • Welch LS (2003) Asbestos claims trust. LitigationDataSource.com

    Google Scholar 

  • Yankelevitz DF et al. (1999) Small pulmonary nodules: evaluation with repeat CT-preliminary experience. Radiology 212:561–566

    CAS  PubMed  Google Scholar 

  • Yoshimura A et al. (1999) A pilot study of lung cancer screening with low-dose spiral CT. Europ Respir J 14(Suppl 30)415s–416s

    Google Scholar 

References

  • American Cancer Society (2005) Statistics 2005. Cancer facts and figures. Available from: URL: http://www.cancer.org Accessed 10/11/05

    Google Scholar 

  • Bastarrika G, Garcia Velloso MJ, Lozano MD, Montes U, Torre W, Spiteri N, Campo A, Seijo L, Alcaide AB, Pueyo JC, Cano D, Vivas I, Cosin O, Dominguez P, Serra P, Richter JA, Monteuenga L, Zulueta JJ (2005) Early lung cancer detection with spiral computed tomography and positron emission tomography. Am J Respir Crit Care Med 171:1378–1383

    PubMed  Google Scholar 

  • Carter D, Vazquez M, Flieder DB, Brambilla E, Gazdar A, Noguchi M, Travis WD, Kramer A, Yip R, Yankelevitz DF, Henschke CI, ELCAP and NY-ELCAP Investigators (Submitted) CT screening for lung cancer: comparison of pathologic findings of baseline and annual repeat cancers. Submitted

    Google Scholar 

  • Chirikos TN, Hazelton T, Tockman M et al. (2002) Screening for lung cancer with CT: a preliminary cost-effectiveness analysis. Chest 121:1507–1514

    PubMed  Google Scholar 

  • Diederich S, Wormanns D, Semik M, Thomas M, Lenzen H, Roos N, Heindel W (2002) Screening for early lung cancer with low-dose spiral CT: prevalence in 817 asymptomatic smokers. Radiology 222:773–781

    PubMed  Google Scholar 

  • Finnish Institute of Occupational Health (2000) Finland National Screening Seminar, Helsinki, Finland, Feb 10, 2000

    Google Scholar 

  • Flehinger BJ, Kimmel M, Melamed MR (1992) Survival from early lung cancer: implications for screening. Chest 101:1013–1018

    CAS  PubMed  Google Scholar 

  • Frimat P, Paris C, Letourneux M, Catilina P, Sobaszek A (1999) Screening of diseases associated with asbestos. On-going activities, synthesis [French]. Rev Mal Respir 16(6 Pt 2):1350–1355

    CAS  PubMed  Google Scholar 

  • Grady D (1999) CAT scan process could cut deaths from lung cancer. Small tumors detected. New York Times, July 9 1999, p 1

    Google Scholar 

  • Henschke CI, McCauley DI, Yankelevitz DF, Naidich DP, McGuinness G, Miettinen OS et al. (1999) Early Lung Cancer Action Project: overall design and findings from baseline screening. Lancet 354:99–105

    CAS  PubMed  Google Scholar 

  • Henschke CI, Miettinen OS, Yankelevitz DF, Libby D, Smith JP (1994) Radiographic screening for cancer: new paradigm for its scientific basis. Clin Imag 18:16–20

    CAS  Google Scholar 

  • Henschke CI, Naidich DP, Yankelevitz DF, McCauley DI. McGuinness G, Smith JP, Libby DM, Pasmantier MW, Koizumi J, Vazquez M, Flieder D, Altorki NK, Miettinen OS (2001) Early Lung Cancer Action Project: initial findings on repeat screening. Cancer 92:153–159

    CAS  PubMed  Google Scholar 

  • Henschke CI, Shaham D, Yankelevitz DF, Kramer A, Reeves AP, Vazquez DF, Miettinen OS (2006) CT screening for lung cancer: significance of diagnoses in its baseline cycle. Clin Imag 30:11–15

    Google Scholar 

  • Henschke CI, Wisnivesky JP, Yankelevitz DF, Miettinen OS (2003) Screen-diagnosed small Stage I cancers of the lung: genuineness and curability. Lung Cancer 39:327–330

    PubMed  Google Scholar 

  • Henschke CI, Yankelevitz DF, Mirtcheva R, McGuinness G, McCauley D, Miettinen OS (2002) CT screening for lung cancer: frequency and significance of part-solid and nonsolid nodules. AJR 178:1053–1057

    PubMed  Google Scholar 

  • Henschke CI, Yankelevitz DF, Naidich D, McCauley DI, McGuinness G, Libby DM, Smith JP, Pasmantier MW, Miettinen OS (2004) CT screening for lung cancer: suspiciousness of nodules at baseline according to size. Radiology 231:164–168

    PubMed  Google Scholar 

  • Henschke CI, Yankelevitz DF, Smith JP, Libby D, Pasmantier MW, McCauley DI, McGuinness G, Naidich DP, Farooqi A, Vazquez M, Miettinen OS (2004) CT screening for lung cancer: assessing a regimen’s diagnostic performance. Clin Imag 28:317–321

    Google Scholar 

  • Henschke CI, Yankelevitz DF, Smith JP, Miettinen OS (2002) Screening for lung cancer: the Early Lung Cancer Action approach. Lung Cancer 35:143–148

    PubMed  Google Scholar 

  • Henschke CI, Yankelevitz DF, Smith JP, Miettinen OS (2002) The use of spiral CT in lung cancer screening. In: DeVita VT, Hellman S, Rosenberg SA (eds) Progress in oncology 2002. Jones and Barlett, Sudbury MA

    Google Scholar 

  • Henschke CI, Yip R, Yankelevitz DF, Miettinen OS (2005) Computed tomography screening for lung cancer: prospects of surviving competing causes of death. Submitted (Abstract presented at ASCO 2005)

    Google Scholar 

  • Hill AB (1990) Suspended judgment. Memories of the British Streptomycin Trial in Tuberculosis. The first randomized clinical trial. Control Clin Trials 11:77–79

    CAS  PubMed  Google Scholar 

  • I-ELCAP (1999) International Conferences on Screening for Lung Cancer. Consensus statements of 1st to 13th Conference. (Website: http://www.IELCAP.org)

    Google Scholar 

  • I-ELCAP (2005) The I-ELCAP Investigators. CT Screening for lung cancer: individualizing the benefit of screening. Submitted (Abstract presented at ASCO 2005)

    Google Scholar 

  • I-ELCAP (2006) I-ELCAP Investigators. CT screening for lung cancer: the relationship of disease stage to tumor size. Arch Int Med. In press

    Google Scholar 

  • Inoue K, Sato M, Fujimura S, Sakurada A, Usuda K, Kondo T, Tanita T, Handa M, Saito Y, Sagawa M (1998) Prognostic assessment of 1310 patients with non-small-cell lung cancer who underwent complete resection from 1980 to 1993. Jpn J Thorac Cardiovasc Surg 116:407–411

    CAS  Google Scholar 

  • Jackson VP (2002) Screening mammography: controversies and headlines. Radiology 225:323–326

    PubMed  Google Scholar 

  • Koskinen K, Rinne JP, Zitting A, Tossavainen A, Kivekas J, Reijula K, Roto P, Huuskonen MS (1996) Screening for asbestos-induced diseases in Finland. Am J Ind Med 30(3):241–251

    CAS  PubMed  Google Scholar 

  • Kostis WJ, Reeves AP, Yankelevitz DF, Henschke CI (2003) Three-dimensional segmentation and growth-rate estimation of small pulmonary nodules in helical CT images. IEEE Trans Med Imag 22:1259–1274

    Google Scholar 

  • Kostis WJ, Yankelevitz DF, Reeves AP, Fluture SC, Henschke CI (2004) Small pulmonary nodules: reproducibility of three-dimensional volumetric measurement and estimation of time to follow-up CT. Radiology 231:446–452

    PubMed  Google Scholar 

  • Mahadevia PJ, Fleisher LA, Frick K et al. (2003) Lung cancer screening with helical computed tomography in older adult smokers: a decision and cost-effectiveness analysis. JAMA 289:313–322

    PubMed  Google Scholar 

  • Marshall D, Simpson KN, Earle C et al. (2001a) Potential cost-effectiveness of one-time screening for lung cancer (LC) in a high risk cohort. Lung Cancer 32:227–236

    CAS  PubMed  Google Scholar 

  • Marshall D, Simpson KN, Earle C et al. (2001b) Economic decision analysis model of screening for lung cancer. Eur J Cancer 37:1759–1767

    CAS  PubMed  Google Scholar 

  • Miettinen OS, Henschke CI, Pasmantier MW, Smith JP, Libby DM, Yankelevitz DF (2002a) Mammographic screening: no reliable supporting evidence? Lancet 359:404–405

    PubMed  Google Scholar 

  • Miettinen OS, Henschke CI, Pasmantier MW, Smith JP, Libby DM, Yankelevitz DF (2002b) Mammographic screening: No reliable supporting evidence? http://www.lancet.com Feb 2, 2002

    Google Scholar 

  • Minniti S, Valentini M, Pozzi Mucelli R (2005) Low-dose helical chest CT in asbestos-exposed workers in the Veneto Region: preliminary results. Radiol Med (Torino) 110:317–324

    Google Scholar 

  • Mountain CF (1997) Revisions in the international system for staging lung cancer. Chest 111:1710–1717

    CAS  PubMed  Google Scholar 

  • Muravov OI, Kaye WE, Lewin M, Berkowitz Z, Lybarger JA, Campolucci SS, Parker JE (2005) The usefulness of computed tomography in detecting asbestos-related pleural abnormalities in people who had indeterminate chest radiographs: the Libby, MT, experience. Int J Hyg Environ Health 208:87–99

    CAS  PubMed  Google Scholar 

  • Shaham D, Breuer R, Coppel L et al. (In press) Hadassah Early Lung Cancer Action Project. Findings on baseline and annual repeat screening of an I-ELCAP study. Clin Lung Cancer

    Google Scholar 

  • Sobue T, Suzuki R, Matsuda M, Kuroishi T, Ikeda S, Naruke T (1992) Survival for clinical stage I lung cancer not surgically treated. Cancer 69:685–692

    CAS  PubMed  Google Scholar 

  • Sone S, Li F, Yang Z-G, Honda T, Maruyama Y, Takashima S, Hasegawa M, Kawakami S, Kubo K, Haniuda M, Yamanda T (2001) Results of three-year mass screening programme for lung cancer using mobile low-dose spiral computed tomography scanner. Br J Cancer 84:25–32

    CAS  PubMed  Google Scholar 

  • Sone S, Takahima S, Li F, Yang Z et al. (1998) Mass screening for lung cancer with mobile spiral computed tomography scanner. Lancet 351:1242–1245

    CAS  PubMed  Google Scholar 

  • Straif K, Silverstein M (1997) Comparison of U.S. Occupational Safety and Health Administration standards and German Berufsgenossenschaften Guidelines for Preventive Occupational Health Examinations. Am J Ind Med 31(4):373–380

    CAS  PubMed  Google Scholar 

  • Swensen SJ, Jett JR, Sloan JA, Midthun DE, Hartman TE, Sykes AM, Augenbaugh GL, Zink FE, Hillman SL, Noetzel GR, Marks RS, Clayton AC, Pairolero PC (2002) Screening for lung cancer with low-dose spiral computed tomography. Am J Respir Crit Care Med 165:508–513

    PubMed  Google Scholar 

  • Tiitola M, Kivisaari L, Huuskonen MS, Mattson K, Koskinen H, Lehtola H, Zitting A, Vehmas T (2002) Computed tomography screening for lung cancer in asbestosexposed workers. Lung Cancer 35:17–22

    PubMed  Google Scholar 

  • Travis WD, Brambilla E, Muller-Hermelink HK, Harris CC (2004) World Health Organization classification of tumours. Pathology and genetics of tumours of the lung, pleura, thymus and heart. IARC Press, Lyon

    Google Scholar 

  • Vazquez M, Flieder D, Travis W, Carter D, Yankelevitz D, Miettinen OS, Henschke CI (2003) Early Lung Cancer Action Project Pathology Protocol. Lung Cancer 39:231–232

    PubMed  Google Scholar 

  • Wisnivesky JP, Mushlin A, Sicherman N, Henschke CI (2003) Cost-effectiveness of baseline low-dose CT screening for lung cancer: preliminary results. Chest 124:614–621

    PubMed  Google Scholar 

  • Yankelevitz DF, Gupta R, Zhao B, Henschke CI (1999) Repeat CT scanning for evaluation of small pulmonary nodules: preliminary results. Radiology 212:561–566

    CAS  PubMed  Google Scholar 

  • Yankelevitz DF, Reeves A, Kostis W, Zhao B, Henschke CI (2000) Determination of malignancy in small pulmonary nodules based on volumetrically determined growth rates: preliminary results. Radiology 217:251–256

    CAS  PubMed  Google Scholar 

References

  • Beigelman-Aubry C, Hill C, Grenier PA (2007) Management of an incidentally discovered pulmonary nodule. Eur Radiol 17:449–466

    PubMed  Google Scholar 

  • Buck AK, Hetzel M, Schirrmeister H, Halter G, Moller P, Kratochwil C, Wahl A, Glatting G, Mottaghy FM, Mattfeldt T, Neumaier B, Reske SN (2005) Clinical relevance of imaging proliferative activity in lung nodules. Eur J Nucl Med Mol Imaging 32(5):525–533

    PubMed  Google Scholar 

  • Christensen JA, Nathan MA, Mullan BP, Hartman TE, Swensen SJ, Lowe VJ (2006) Characterization of the solitary pulmonary nodule: 18F-FDG PET versus noduleenhancement CT AJR Am J Roentgenol 187(5):1361–1367

    Google Scholar 

  • Devaraj A, Cook GJR, Hansell DM (2007) PET/CT in nonsmall cell lung cancer staging-promises and problems. Clin Radiol 62(2):97–108

    CAS  PubMed  Google Scholar 

  • Erasmus JJ, McAdams HP, Connolly JE (2000a) Solitary pulmonary nodules. Part II. Evaluation of the indeterminate nodule. RadioGraphics 20:59–66

    CAS  PubMed  Google Scholar 

  • Erasmus JJ, Connolly JE, McAdams HP, Roggli VL (2000b) Solitary pulmonary nodules. Part I. Morphologic evaluation for differentiation of benign and malignant lesions. Radiographics 20:43–58

    CAS  PubMed  Google Scholar 

  • Gagel B, Reinartz P, Demirel C, Kaiser HJ, Zimny M, Piroth M, Pinkawa M, Stanzel S, Asadpour B, Hamacher K, Coenen HH, Buell U, Eble MJ (2006) [18F] fluoromisonidazole and [18F] fluorodeoxyglucose positron emission tomography in response evaluation after chemo-/radiotherapy of non-small-cell lung cancer: a feasibility study. BMC Cancer 6:51

    PubMed  Google Scholar 

  • Grewal RG, Austin JH (1994) CT demonstration of calcification in carcinoma of the lung. J Comput Assist Tomogr 18:867–871

    CAS  PubMed  Google Scholar 

  • Guckel C, Schnabel K, Deimling M, Steinbrich W (1996) Solitary pulmonary nodules: MR evaluation of enhancement patterns with contrast-enhanced dynamic snapshot gradient-echo imaging. Radiology 200:681–686

    CAS  PubMed  Google Scholar 

  • Herder GJ, Golding RP, Hoekstra OS et al. (2004) The performance of 18F-fluorodeoxyglucose positron emission tomography in small solitary pulmonary nodules. Eur J Nucl Med Mol Imaging 31:1231–1236

    PubMed  Google Scholar 

  • Hittmair K, Eckersberger F, Klepetko W, Helbich T, Herold CJ (1995) Evaluation of solitary pulmonary nodules with dynamic contrast-enhanced MR imaging—a promising technique. Magn Reson Imaging 13:923–933

    CAS  PubMed  Google Scholar 

  • Hoekstra CJ, Stroobants SG, Hoekstra OS, Smit EF, Vansteenkiste JF, Lammertsma AA (2002) Measurement of perfusion in stage IIIA-N2 non-small cell lung cancer using H(2)(15)O and positron emission tomography. Clin Cancer Res 8(7):2109–2115

    PubMed  Google Scholar 

  • Jennings SG, Winer-Muram HT, Tarver RD, Farber MO (2004) Lung tumor growth: assessment with CT-comparison of diameter and cross-sectional area with volume measurements. Radiology 231:866–871

    PubMed  Google Scholar 

  • Jeong YJ, Lee KS, Jeong SY et al. (2005) Solitary pulmonary nodule: characterization with combined wash-in and washout features at dynamic multi-detector row CT. Radiology 237:675–683

    PubMed  Google Scholar 

  • Kim JH, Kim HJ, Lee KH, Kim KH, Lee HL (2004) Solitary pulmonary nodules: a comparative study evaluated with contrast-enhanced dynamic MR imaging and CT. J Comput Assist Tomogr 28:766–775

    PubMed  Google Scholar 

  • Kui M, Templeton PA, White CS, Cai ZL, Bai YX, Cai YQ (1996) Evaluation of the air bronchogram sign on CT in solitary pulmonary lesions. J Comput Assist Tomogr 20:983–986

    CAS  PubMed  Google Scholar 

  • Lee KS, Jeong YJ, Han J, Kim BT, Kim H, Kwon OJ (2004) T1 non-small cell lung cancer: imaging and histopathologic findings and their prognostic implications. RadioGraphics 24:1617–1636

    PubMed  Google Scholar 

  • Lowe VJ, Fletcher JW, Gobar L et al. (1998) Prospective investigation of positron emission tomography in lung nodules. J Clin Oncol 16:1075–1084

    CAS  PubMed  Google Scholar 

  • Mahoney MC, Shipley RT, Corcoran HL, Dickson BA (1990) CT demonstration of calcification in carcinoma of the lung. AJR Am J Roentgenol 154:255–258

    CAS  PubMed  Google Scholar 

  • Marten K, Rummeny EJ, Engelke C (2005) Computer-aided diagnosis and volumetry of pulmonary nodules: current concepts and future perspectives. Rofo 177:188–196

    CAS  PubMed  Google Scholar 

  • Mineura K, Yasuda T, Kowada M et al. (1986) Positron emission tomographic evaluation of histological malignancy in gliomas using oxygen-15 and fluorine-18-fluorodeoxyglucose. Neurol Res 8:164–168

    CAS  PubMed  Google Scholar 

  • Munden RF, Hess KR (2001) “Ditzels” on chest CT: urvey of members of the Society of Thoracic Radiology. AJR Am J Roentgenol 176:1363–1369

    CAS  PubMed  Google Scholar 

  • Muram TM, Aisen A (2003) Fatty metastatic lesions in 2 patients with renal clear-cell carcinoma. J Comput Assist Tomogr 27:869–870

    PubMed  Google Scholar 

  • Ohno Y, Hatabu H, Takenaka D, Adachi S, Kono M, Sugimura K (2002) Solitary pulmonary nodules: potential role of dynamic MR imaging in management initial experience. Radiology 224:503–511

    PubMed  Google Scholar 

  • Schaefer JF, Vollmar J, Schick F et al. (2004) Solitary pulmonary nodules: dynamic contrast-enhanced MR imaging-perfusion differences in malignant and benign lesions. Radiology 232:544–553

    PubMed  Google Scholar 

  • Swensen SJ (2000) Functional CT: lung nodule evaluation. Radiographics 20:1178–1181

    CAS  PubMed  Google Scholar 

  • Swensen SJ, Viggiano RW, Midthun DE et al. (2000) Lung nodule enhancement at CT: multicenter study. Radiology 214:73–80

    CAS  PubMed  Google Scholar 

  • Tateishi U, Kusumoto M, Nishihara H, Nagashima K, Morikawa T, Moriyama N (2002) Contrast-enhanced dynamic computed tomography for the evaluation of tumor angiogenesis in patients with lung carcinoma. Cancer 95:835–842

    PubMed  Google Scholar 

  • Winer-Muram HT (2006) The solitary pulmonary nodule. Radiology 239:34–49

    PubMed  Google Scholar 

  • Woodring JH, Fried AM, Chuang VP (1980) Solitary cavities of the lung: diagnostic implications of cavity wall thickness. AJR Am J Roentgenol 135:1269–1271

    CAS  PubMed  Google Scholar 

  • Yi CA, Lee KS, Kim EA et al. (2004) Solitary pulmonary nodules: dynamic enhanced multi-detector row CT study and comparison with vascular endothelial growth factor and microvessel density. Radiology 233:191–199

    PubMed  Google Scholar 

  • Yi CA, Lee KS, Kim B-T et al. (2006) Tissue characterization of solitary pulmonary nodule: comparative study between helical dynamic CT and integrated PET/CT. J Nucl Med 47:443–450

    PubMed  Google Scholar 

  • Yoon HE, Fukuhara K, Michiura T et al. (2005) Pulmonary nodules 10 mm or less in diameter with ground-glass opacity component detected by high-resolution computed tomography have a high possibility of malignancy. Jpn J Thorac Cardiovasc Surg 53:22–28

    PubMed  Google Scholar 

  • Zhang M, Kono M (1997) Solitary pulmonary nodules: evaluation of blood flow patterns with dynamic CT. Radiology 205:471–478

    CAS  PubMed  Google Scholar 

  • Zwirewich CV, Vedal S, Miller RR, Muller NL (1991) Solitary pulmonary nodule: high-resolution CT and radiologicpathologic correlation. Radiology 179:469–476

    CAS  PubMed  Google Scholar 

References

  • Achiron R, Lipitz S, Sivan E et al. (1995a) Changes mimicking endometrial neoplasia in postmenopausal, tamoxifen-treated women with breast cancer: a transvaginal Doppler study. Ultrasound Obstet Gynecol 6(2):116–120

    CAS  PubMed  Google Scholar 

  • Achiron R, Lipitz S, Sivan E et al. (1995b) Sonohysterography for ultrasonographic evaluation of tamoxifen-associated cystic thickened endometrium. J Ultrasound Med 14(9):685–688

    CAS  PubMed  Google Scholar 

  • ACOG (2001) ACOG committee opinion. Tamoxifen and endometrial cancer. Int J Gynaecol Obstet 73(1):77–79

    Google Scholar 

  • ACOG (2002) ACOG Practice Bulletin. Clinical management guidelines for obstetrician-gynecologists. Number 39, October 2002. Selective estrogen receptor modulators. Obstet Gynecol 100(4):835–843

    Google Scholar 

  • Althuis MD, Sexton M, Langenberg P et al. (2000) Surveillance for uterine abnormalities in tamoxifen-treated breast carcinoma survivors: a community based study. Cancer 89(4):800–810

    CAS  PubMed  Google Scholar 

  • Andersson M, Storm HH, Mouridsen HAT (1991) Incidence of new primary cancers after adjuvant tamoxifen therapy and radiotherapy for early breast cancer. J Natl Cancer Inst 83(14):1013–1017

    CAS  PubMed  Google Scholar 

  • Ascher SM, Johnson JC, Barnes WA et al. (1996) MR imaging appearance of the uterus in postmenopausal women receiving tamoxifen therapy for breast cancer: histopathologic correlation. Radiology 200(1):105–110

    CAS  PubMed  Google Scholar 

  • Ascher SM, Imaoka I, Lage JM (2000) Tamoxifen-induced uterine abnormalities: the role of imaging. Radiology 214(1):29–38

    CAS  PubMed  Google Scholar 

  • Ascher SM, Johnson J, Zeman RK, Patt RH (1995) Uterine changes in women receiving tamoxifen therapy: prospective comparison of MR imaging and transvaginal sonography with pathologic correlation (abstr). Radiology 197(P):353–354

    Google Scholar 

  • Assikis VJ, Neven P, Jordan VC et al. (1996) A realistic clinical perspective of tamoxifen and endometrial carcinogenesis. Eur J Cancer 32A(9):1464–7146

    CAS  PubMed  Google Scholar 

  • Atri M, Nazarnia S, Aldis AE et al. (1994) Transvaginal US appearance of endometrial abnormalities. Radiographics 14(3):483–492

    CAS  PubMed  Google Scholar 

  • Baldwin MT, Dudiak KM, Gorman B et al. (1999) Focal intracavitary masses recognized with the hyperechoic line sign at endovaginal US and characterized with hysterosonography. Radiographics 19(4):927–935

    CAS  PubMed  Google Scholar 

  • Barakat RR (1996) Tamoxifen and endometrial neoplasia. Clin Obstet Gynecol 39(3):629–640

    CAS  PubMed  Google Scholar 

  • Barakat RR, Gilewski TA, Almadrones L et al. (2000) Effect of adjuvant tamoxifen on the endometrium in women with breast cancer: a prospective study using office endometrial biopsy. J Clin Oncol 18(20):3459–3463

    CAS  PubMed  Google Scholar 

  • Bergman L, Beelen ML, Gallee MP et al. (2000) Risk and prognosis of endometrial cancer after tamoxifen for breast cancer. Comprehensive Cancer Centres’ ALERT Group. Assessment of Liver and Endometrial cancer Risk following Tamoxifen. Lancet 356(9233):881–887

    CAS  PubMed  Google Scholar 

  • Berliere M, Charles A, Galant C et al. (1998) Uterine side effects of tamoxifen: a need for systematic pretreatment screening. Obstet Gynecol 91(1):40–44

    CAS  PubMed  Google Scholar 

  • Bourne TH, Lawton F, Leather A et al. (1994) Use of intracavity saline instillation and transvaginal ultrasonography to detect tamoxifen-associated endometrial polyps. Ultrasound Obstet Gynecol 4(1):73–75

    CAS  PubMed  Google Scholar 

  • Cardosi RJ, Fiorica JV (2000) Surveillance of the endometrium in tamoxifen treated women. Curr Opin Obstet Gynecol 12(1):27–31

    CAS  PubMed  Google Scholar 

  • Cecchini S, Ciatto S, Bonardi R et al. (1996) Screening by ultrasonography for endometrial carcinoma in postmenopausal breast cancer patients under adjuvant tamoxifen. Gynecol Oncol 60(3):409–411

    CAS  PubMed  Google Scholar 

  • Cheng WF, Lin HH, Torng PL et al. (1997) Comparison of endometrial changes among symptomatic tamoxifentreated and nontreated premenopausal and postmenopausal breast cancer patients. Gynecol Oncol 66(2):233–237

    CAS  PubMed  Google Scholar 

  • Cohen CJ (1997) Tamoxifen and endometrial cancer: tamoxifen effects on the human female genital tract. Semin Oncol 24(1 Suppl 1):S1-55–S1-64

    Google Scholar 

  • Cohen I, Rosen DJ, Tepper R et al. (1993) Ultrasonographic evaluation of the endometrium and correlation with endometrial sampling in postmenopausal patients treated with tamoxifen. J Ultrasound Med 12(5):275–280

    CAS  PubMed  Google Scholar 

  • Cohen I, Altaras MM, Shapira J et al. (1994a) Postmenopausal tamoxifen treatment and endometrial pathology. Obstet Gynecol Surv 49(12):823–829

    CAS  PubMed  Google Scholar 

  • Cohen I, Rosen DJ, Shapira J et al. (1994b) Endometrial changes with tamoxifen: comparison between tamoxifentreated and nontreated asymptomatic, postmenopausal breast cancer patients. Gynecol Oncol 52(2):185–190

    CAS  PubMed  Google Scholar 

  • Cohen I, Beyth Y, Tepper R et al. (1995) Adenomyosis in postmenopausal breast cancer patients treated with tamoxifen: a new entity? Gynecol Oncol 58(1):86–91

    CAS  PubMed  Google Scholar 

  • Cohen I, Bernheim J, Azaria R et al. (1999) Malignant endometrial polyps in postmenopausal breast cancer tamoxifen-treated patients. Gynecol Oncol 75(1):136–141

    CAS  PubMed  Google Scholar 

  • Cohen I (2004) Endometrial pathologies associated with postmenopausal tamoxifen treatment. Gynecol Oncol 94(2):256–266

    CAS  PubMed  Google Scholar 

  • Corley D, Rowe J, Curtis MT et al. (1992) Postmenopausal bleeding from unusual endometrial polyps in women on chronic tamoxifen therapy. Obstet Gynecol 79(1):111–116

    CAS  PubMed  Google Scholar 

  • Cullinan JA, Fleischer AC, Kepple DM et al. (1995) Sonohysterography: a technique for endometrial evaluation. Radiographics 15(3):501–514; discussion 515–516

    CAS  PubMed  Google Scholar 

  • Curtis RE, Boice JD Jr, Shriner DA et al. (1996) Second cancers after adjuvant tamoxifen therapy for breast cancer. J Natl Cancer Inst 88(12):832–834

    CAS  PubMed  Google Scholar 

  • De Muylder X, Neven P, De Somer M et al. (1991) Endometrial lesions in patients undergoing tamoxifen therapy. Int J Gynaecol Obstet 36(2):127–130

    PubMed  Google Scholar 

  • Deligdisch L, Kalir T, Cohen CJ et al. (2000) Endometrial histopathology in 700 patients treated with tamoxifen for breast cancer. Gynecol Oncol 78(2):181–186

    CAS  PubMed  Google Scholar 

  • DelMaschio A, Vanzulli A, Sironi S et al. (1993) Estimating the depth of myometrial involvement by endometrial carcinoma: efficacy of transvaginal sonography vs MR imaging. AJR Am J Roentgenol 160(3):533–538

    CAS  PubMed  Google Scholar 

  • Develioglu OH, Omak M, Bilgin T et al. (2004) The endometrium in asymptomatic breast cancer patients on tamoxifen: value of transvaginal ultrasonography with saline infusion and Doppler flow. Gynecol Oncol 93(2):328–335

    CAS  PubMed  Google Scholar 

  • Dilts PV Jr, Hopkins MP, Chang AE et al. (1992) Rapid growth of leiomyoma in patient receiving tamoxifen. Am J Obstet Gynecol 166(1 Pt 1):167–168

    PubMed  Google Scholar 

  • Dubinsky TJ, Parvey HR, Maklad N (1997) The role of transvaginal sonography and endometrial biopsy in the evaluation of peri-and postmenopausal bleeding. AJR Am J Roentgenol 169(1):145–149

    CAS  PubMed  Google Scholar 

  • Early Breast Cancer Trialists’ Collaborative Group (1992) Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy: 133 randomised trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Lancet 339(8785):71–85

    Google Scholar 

  • Early Breast Cancer Trialists’ Collaborative Group (1998) Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists’ Collaborative Group (1998) Lancet 351(9114):1451–146

    Google Scholar 

  • Ferrazzi E, Leone FP (2004) Investigating abnormal bleeding on HRT or tamoxifen: the role of ultrasonography. Best Pract Res Clin Obstet Gynaecol 18(1):145–156

    PubMed  Google Scholar 

  • Fisher B, Costantino JP, Redmond CK et al. (1994) Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14. J Natl Cancer Inst 86(7):527–537

    CAS  PubMed  Google Scholar 

  • Fisher B, Costantino JP, Wickerham DL et al. (1998) Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst 90(18):1371–1388

    CAS  PubMed  Google Scholar 

  • Fisher B, Jeong JH, Dignam J et al. (2001) Findings from recent National Surgical Adjuvant Breast and Bowel Project adjuvant studies in stage I breast cancer. J Natl Cancer Inst Monogr 30):62–66

    PubMed  Google Scholar 

  • Fong K, Kung R, Lytwyn A et al. (2001) Endometrial evaluation with transvaginal US and hysterosonography in asymptomatic postmenopausal women with breast cancer receiving tamoxifen. Radiology 220(3):765–773

    CAS  PubMed  Google Scholar 

  • Fong K, Causer P, Atri M et al. (2003) Transvaginal US and hysterosonography in postmenopausal women with breast cancer receiving tamoxifen: correlation with hysteroscopy and pathologic study. Radiographics 23(1):137–150; discussion 151–155

    PubMed  Google Scholar 

  • Forbes JF (1997) The control of breast cancer: the role of tamoxifen. Semin Oncol 24(1 Suppl 1):S1-5–S1-19

    Google Scholar 

  • Fornander T, Rutqvist LE, Cedermark B et al. (1989) Adjuvant tamoxifen in early breast cancer: occurrence of new primary cancers. Lancet 1(8630):117–120

    CAS  PubMed  Google Scholar 

  • Franchi M, Ghezzi F, Donadello N et al. (1999) Endometrial thickness in tamoxifen-treated patients: an independent predictor of endometrial disease. Obstet Gynecol 93(6):1004–1008

    CAS  PubMed  Google Scholar 

  • Freedman AN, Graubard BI, Rao SR et al. (2003) Estimates of the number of US women who could benefit from tamoxifen for breast cancer chemoprevention. J Natl Cancer Inst 95(7):526–532

    CAS  PubMed  Google Scholar 

  • Fung MF, Reid A, Faught W et al. (2003) Prospective longitudinal study of ultrasound screening for endometrial abnormalities in women with breast cancer receiving tamoxifen. Gynecol Oncol 91(1):154–159

    CAS  PubMed  Google Scholar 

  • Gal D, Kopel S, Bashevkin M et al. (1991) Oncogenic potential of tamoxifen on endometria of postmenopausal women with breast cancer-preliminary report. Gynecol Oncol 42(2):120–123

    CAS  PubMed  Google Scholar 

  • Gerber B, Krause A, Muller H et al. (2000) Effects of adjuvant tamoxifen on the endometrium in postmenopausal women with breast cancer: a prospective long-term study using transvaginal ultrasound. J Clin Oncol 18(20):3464–3470

    CAS  PubMed  Google Scholar 

  • Goldstein SR, Nachtigall M, Snyder JR et al. (1990) Endometrial assessment by vaginal ultrasonography before endometrial sampling in patients with postmenopausal bleeding. Am J Obstet Gynecol 163(1 Pt 1):119–123

    CAS  PubMed  Google Scholar 

  • Goldstein SR (1994) Unusual ultrasonographic appearance of the uterus in patients receiving tamoxifen. Am J Obstet Gynecol 170(2):447–451

    CAS  PubMed  Google Scholar 

  • Gompel C SS (1994) Pathology in gynecology and obstetrics. The corpus uteri, ed. Gompel C SS. Vol. 4th edition. Lippincott, Philadelphia, pp 163–283

    Google Scholar 

  • Granberg S, Wikland M, Karlsson B et al. (1991) Endometrial thickness as measured by endovaginal ultrasonography for identifying endometrial abnormality. Am J Obstet Gynecol 164(1 Pt 1):47–52

    CAS  PubMed  Google Scholar 

  • Hann LE, Giess CS, Bach AM et al. (1997) Endometrial thickness in tamoxifen-treated patients: correlation with clinical and pathologic findings. AJR Am J Roentgenol 168(3):657–661

    CAS  PubMed  Google Scholar 

  • Hann LE, Kim CM, Gonen M et al. (2003) Sonohysterography compared with endometrial biopsy for evaluation of the endometrium in tamoxifen-treated women. J Ultrasound Med 22(11):1173–1179

    PubMed  Google Scholar 

  • Hricak H, Stern JL, Fisher MR et al. (1987) Endometrial carcinoma staging by MR imaging. Radiology 162(2):297–305

    CAS  PubMed  Google Scholar 

  • Hricak H, Hamm B, Semelka RC et al. (1991) Carcinoma of the uterus: use of gadopentetate dimeglumine in MR imaging. Radiology 181(1):95–106

    CAS  PubMed  Google Scholar 

  • Hricak H, Finck S, Honda G et al. (1992) MR imaging in the evaluation of benign uterine masses: value of gadopentetate dimeglumine-enhanced T1-weighted images. AJR Am J Roentgenol 158(5):1043–1050

    CAS  PubMed  Google Scholar 

  • Hulka CA, Hall DA (1993) Endometrial abnormalities associated with tamoxifen therapy for breast cancer: sonographic and pathologic correlation. AJR Am J Roentgenol 160(4):809–812

    CAS  PubMed  Google Scholar 

  • Ismail SM (1994) Pathology of endometrium treated with tamoxifen. J Clin Pathol 47(9):827–833

    CAS  PubMed  Google Scholar 

  • IARC (1996) International Agency for Research on Cancer Consensus report. Mechanisms of fibre carcinogenesis. IARC Sci Publ 140):1–9

    Google Scholar 

  • Ito K, Matsumoto T, Nakada T et al. (1994) Assessing myometrial invasion by endometrial carcinoma with dynamic MRI. J Comput Assist Tomogr 18(1):77–86

    CAS  PubMed  Google Scholar 

  • Ito T, Katagiri C, Murata Y et al. (2001) Indication for histological examination of endometrium in breast carcinoma patients receiving tamoxifen therapy. J Obstet Gynaecol Res 27(3):141–145

    CAS  PubMed  Google Scholar 

  • Jaiyesimi IA, Buzdar AU, Decker DA et al. (1995) Use of tamoxifen for breast cancer: twenty-eight years later. J Clin Oncol 13(2):513–529

    CAS  PubMed  Google Scholar 

  • Karlsson B, Granberg S, Wikland M et al. (1995) Transvaginal ultrasonography of the endometrium in women with postmenopausal bleeding — a Nordic multicenter study. Am J Obstet Gynecol 172(5):1488–1494

    CAS  PubMed  Google Scholar 

  • Kedar RP, Bourne TH, Powles TJ et al. (1994) Effects of tamoxifen on uterus and ovaries of postmenopausal women in a randomised breast cancer prevention trial. Lancet 343(8909):1318–1321

    CAS  PubMed  Google Scholar 

  • Kolata G FL (1998) Drugs to fight breast cancer near approval. The New York Times p A18

    Google Scholar 

  • Kurman RJ NH (1994) Endometrial hyperplasia and related cellular changes. In: Blausteins’s pathology of the female genital tract, 4th edn. Springer, Berlin Heidelberg New York, pp 411–437

    Google Scholar 

  • Lahti E, Blanco G, Kauppila A et al. (1993) Endometrial changes in postmenopausal breast cancer patients receiving tamoxifen. Obstet Gynecol 81(5 Pt 1):660–664

    CAS  PubMed  Google Scholar 

  • Laifer-Narin SL, Ragavendra N, Lu DS et al. (1999) Transvaginal saline hysterosonography: characteristics distinguishing malignant and various benign conditions. AJR Am J Roentgenol 172(6):1513–1520

    CAS  PubMed  Google Scholar 

  • Langer RD, Pierce JJ, O’Hanlan KA et al. (1997) Transvaginal ultrasonography compared with endometrial biopsy for the detection of endometrial disease. Postmenopausal Estrogen/Progestin Interventions Trial. N Engl J Med 337(25):1792–1798

    CAS  PubMed  Google Scholar 

  • Lasset C, Bonadona V, Mignotte H et al. (2001) Tamoxifen and risk of endometrial cancer. Lancet 357(9249):66–67

    CAS  PubMed  Google Scholar 

  • Levine D, Gosink BB, Johnson LA (1995) Change in endometrial thickness in postmenopausal women undergoing hormone replacement therapy. Radiology 197(3):603–608

    CAS  PubMed  Google Scholar 

  • Lev-Toaff AS (1996) Sonohysterography: evaluation of endometrial and myometrial abnormalities. Semin Roentgenol 31(4):288–298

    CAS  PubMed  Google Scholar 

  • Lipson SA, Hricak H (1996) MR imaging of the female pelvis. Radiol Clin North Am 34(6):1157–1182

    CAS  PubMed  Google Scholar 

  • Love CD, Muir BB, Scrimgeour JB et al. (1999) Investigation of endometrial abnormalities in asymptomatic women treated with tamoxifen and an evaluation of the role of endometrial screening. J Clin Oncol 17(7):2050–2054

    CAS  PubMed  Google Scholar 

  • Lumsden MA, West CP, Hillier H et al. (1989) Estrogenic action of tamoxifen in women treated with luteinizing hormone-releasing hormone agonists (goserelin)-lack of shrinkage of uterine fibroids. Fertil Steril 52(6):924–929

    CAS  PubMed  Google Scholar 

  • Machado F, Rodriguez JR, Leon JP et al. (2005) Tamoxifen and endometrial cancer. Is screening necessary? A review of the literature. Eur J Gynaecol Oncol 26(3):257–265

    CAS  PubMed  Google Scholar 

  • Magriples U, Naftolin F, Schwartz PE et al. (1993) High-grade endometrial carcinoma in tamoxifen-treated breast cancer patients. J Clin Oncol 11(3):485–490

    CAS  PubMed  Google Scholar 

  • Marconi D, Exacoustos C, Cangi B et al. (1997) Transvaginal sonographic and hysteroscopic findings in postmenopausal women receiving tamoxifen. J Am Assoc Gynecol Laparosc 4(3):331–339

    CAS  PubMed  Google Scholar 

  • McGonigle KF, Shaw SL, Vasilev SA et al. (1998) Abnormalities detected on transvaginal ultrasonography in tamoxifen-treated postmenopausal breast cancer patients may represent endometrial cystic atrophy. Am J Obstet Gynecol 178(6):1145–1150

    CAS  PubMed  Google Scholar 

  • Mignotte H, Lasset C, Bonadona V et al. (1998) Iatrogenic risks of endometrial carcinoma after treatment for breast cancer in a large French case-control study. Federation Nationale des Centres de Lutte Contre le Cancer (FNCLCC). Int J Cancer 76(3):325–330

    CAS  PubMed  Google Scholar 

  • Mourits MJ, Van der Zee AG, Willemse PH et al. (1999) Discrepancy between ultrasonography and hysteroscopy and histology of endometrium in postmenopausal breast cancer patients using tamoxifen. Gynecol Oncol 73(1):21–26

    CAS  PubMed  Google Scholar 

  • Mourits MJ, De Vries EG, Willemse PH et al. (2001) Tamoxifen treatment and gynecologic side effects: a review. Obstet Gynecol 97(5 Pt 2):855–866

    CAS  PubMed  Google Scholar 

  • Narod SA, Pal T, Graham T et al. (2001) Tamoxifen and risk of endometrial cancer. Lancet 357(9249):65–66; author reply 67

    CAS  PubMed  Google Scholar 

  • Nayfield SG, Karp JE, Ford LG et al. (1991) Potential role of tamoxifen in prevention of breast cancer. J Natl Cancer Inst 83(20):1450–1459

    CAS  PubMed  Google Scholar 

  • Neven P, De Muylder X, Van Belle Y et al. (1990) Hysteroscopic follow-up during tamoxifen treatment. Eur J Obstet Gynecol Reprod Biol 35(2–3):235–238

    CAS  PubMed  Google Scholar 

  • Neven P, De Muylder X, Van Belle Y et al. (1998) Longitudinal hysteroscopic follow-up during tamoxifen treatment. Lancet 351(9095):36

    CAS  PubMed  Google Scholar 

  • Neven P, Vergote I (1998) Should tamoxifen users be screened for endometrial lesions? Lancet 351(9097):155–157

    CAS  PubMed  Google Scholar 

  • Neven P, Vernaeve H (2000) Guidelines for monitoring patients taking tamoxifen treatment. Drug Saf 22(1):1–11

    CAS  PubMed  Google Scholar 

  • Osborne CK (1998) Tamoxifen in the treatment of breast cancer. N Engl J Med 339(22):1609–1618

    CAS  PubMed  Google Scholar 

  • Peters-Engl C, Frank W, Danmayr E et al. (1999) Association between endometrial cancer and tamoxifen treatment of breast cancer. Breast Cancer Res Treat 54(3):255–260

    CAS  PubMed  Google Scholar 

  • Ragaz J, Coldman A (1998) Survival impact of adjuvant tamoxifen on competing causes of mortality in breast cancer survivors, with analysis of mortality from contralateral breast cancer, cardiovascular events, endometrial cancer, and thromboembolic episodes. J Clin Oncol 16(6):2018–2024

    CAS  PubMed  Google Scholar 

  • Reinhold C GB, Ascher SM (1997) Uterus and cervix. MRI of the abdomen and pelvis: a text atlas, ed. Semelka RC AS, Reinhold C, New York: Wiley-Liss. 585–660

    Google Scholar 

  • Renard F, Vosse M, Scagnol I et al. (2002) Aggressive endometrial carcinoma in a breast cancer patient treated with tamoxifen with normal transvaginal ultrasonography. Case report. Eur J Gynaecol Oncol 23(1):25–28

    CAS  PubMed  Google Scholar 

  • Schlesinger C, Kamoi S, Ascher SM et al. (1998) Endometrial polyps: a comparison study of patients receiving tamoxifen with two control groups. Int J Gynecol Pathol 17(4):302–311

    CAS  PubMed  Google Scholar 

  • Shipley CF III, Simmons CL, Nelson GH (1994) Comparison of transvaginal sonography with endometrial biopsy in asymptomatic postmenopausal women. J Ultrasound Med 13(2):99–104

    PubMed  Google Scholar 

  • Silva A AS, Ascher S, Reinhold C (1998) Magnetic resonance imaging versus ultrasound in the assessment of benign uterine lesions. Radiology of the femal pelvic organs, ed. E L, Berlin, Heidelberg, New York: Springer-Verlag. pp 43–67

    Google Scholar 

  • Sinawat S (2002) Prevention of endometrial cancer in breast cancer patients taking tamoxifen: the gynecologists’ role. Asian Pac J Cancer Prev 3(3):251–255

    PubMed  Google Scholar 

  • Sladkevicius P, Valentin L, Marsal K (1994) Endometrial thickness and Doppler velocimetry of the uterine arteries as discriminators of endometrial status in women with postmenopausal bleeding: a comparative study. Am J Obstet Gynecol 171(3):722–728

    CAS  PubMed  Google Scholar 

  • Suh-Burgmann EJ, Goodman A (1999) Surveillance for endometrial cancer in women receiving tamoxifen. Ann Intern Med 131(2):127–135

    CAS  PubMed  Google Scholar 

  • Tepper R, Beyth Y, Altaras MM et al. (1997) Value of sonohysterography in asymptomatic postmenopausal tamoxifen-treated patients. Gynecol Oncol 64(3):386–391

    CAS  PubMed  Google Scholar 

  • Ugwumadu AH, Bower D, Ho PK (1993) Tamoxifen induced adenomyosis and adenomyomatous endometrial polyp. Br J Obstet Gynaecol 100(4):386–388

    CAS  PubMed  Google Scholar 

  • Uziely B, Lewin A, Brufman G et al. (1993) The effect of tamoxifen on the endometrium. Breast Cancer Res Treat 26(1):101–105

    CAS  PubMed  Google Scholar 

  • van Leeuwen FE, Benraadt J, Coebergh JW et al. (1994) Risk of endometrial cancer after tamoxifen treatment of breast cancer. Lancet 343(8895):448–452

    PubMed  Google Scholar 

  • Varras M, Polyzos D, Akrivis C (2003) Effects of tamoxifen on the human female genital tract: review of the literature. Eur J Gynaecol Oncol 24(3–4):258–268

    CAS  PubMed  Google Scholar 

  • Vosse M, Renard F, Coibion M et al. (2002) Endometrial disorders in 406 breast cancer patients on tamoxifen: the case for less intensive monitoring. Eur J Obstet Gynecol Reprod Biol 101(1):58–63

    CAS  PubMed  Google Scholar 

  • Wickerham DL, Fisher B, Wolmark N et al. (2002) Association of tamoxifen and uterine sarcoma. J Clin Oncol 20(11):2758–2760

    PubMed  Google Scholar 

  • Wilder JL, Shajahan S, Khattar NH et al. (2004) Tamoxifenassociated malignant endometrial tumors: pathologic features and expression of hormone receptors estrogenalpha, estrogen-beta and progesterone; a case controlled study. Gynecol Oncol 92(2):553–558

    CAS  PubMed  Google Scholar 

  • Wolman I, Jaffa AJ, Hartoov J et al. (1996) Sensitivity and specificity of sonohysterography for the evaluation of the uterine cavity in perimenopausal patients. J Ultrasound Med 15(4):285–288

    CAS  PubMed  Google Scholar 

  • www.astrazeneca.com

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiology, HELIOS Clinics Schwerin, Teaching Hospitals of the University of Rostock, Wismarsche Strasse 393–397, 19049, Schwerin, Germany

    Roger Eibel MD (Chief)

  2. Institute and Outpatient Clinic for Occupational, Social and Environmental Medicine, University of Munich, Ziemssenstrasse 1, 80336, Munich, Germany

    Dennis Nowak MD (Professor)

  3. Department of Radiology, New York Presbyterian Hospital — Weill Cornell Medical Center, 525 East 68th Street, New York, NY, 10065, USA

    Claudia I. Henschke PhD, MD, FCCP, Matthew Cham MD & David F. Yankelevitz MD

  4. Section Chief Cardiothoracic Imaging, Department of Clinical Radiology, University Hospital Mannheim, Medical Faculty Mannheim — University of Heidelberg, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany

    Christian Fink MD (Associate Professor)

  5. Department of Clinical Radiology, University Hospitals — Grosshadern, Ludwig-Maximilians-University of Munich, Marchioninistrasse 15, 81377, Munich, Germany

    Frank Berger MD

  6. Department of Radiology, Georgetown University Hospital, 3800 Reservoir Road NW, Washington DC, 20007-2197, USA

    Sandra A. Polin MD & Sandra J. Allison MD

  7. Division of Abdominal Imaging, Georgetown University Hospital, 3800 Reservoir Road NW, Washington DC, 20007-2197, USA

    Susan M. Ascher MD (Professor, Department of Radiology, Director)

Authors
  1. Roger Eibel MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Dennis Nowak MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Claudia I. Henschke PhD, MD, FCCP
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Matthew Cham MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. David F. Yankelevitz MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Christian Fink MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Frank Berger MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Sandra A. Polin MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Sandra J. Allison MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Susan M. Ascher MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Clinical Radiology, University Hospitals — Grosshadern and Innenstadt Ludwig-Maximilians-University of Munich, Marchioninistrasse 15, 81377, Munich, Germany

    Maximilian F. Reiser MD (Professor and Chairman) (Professor and Chairman)

  2. German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany

    Gerhard van Kaick MD (Professor Emeritus) (Professor Emeritus)

  3. Department of Clinical Radiology University Hospital Mannheim Medical Faculty Mannheim, University of Heidelberg, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany

    Christian Fink MD (Associate Professor Section Chief Cardiothoracic Imaging) & Stefan O. Schoenberg MD (Professor and Chairman) (Associate Professor Section Chief Cardiothoracic Imaging) &  (Professor and Chairman)

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Eibel, R. et al. (2008). Exogenous Exposure: Occupation and Environment. In: Reiser, M.F., van Kaick, G., Fink, C., Schoenberg, S.O. (eds) Screening and Preventive Diagnosis with Radiological Imaging. Medical Radiology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-49831-5_14

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-49831-5_14

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-23553-8

  • Online ISBN: 978-3-540-49831-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation